May. 13 at 2:19 PM
$RVPH And I didn't sell when it went over
$4... Promising drug, but shit management. Lax was a prime example of the worst possible decision at every turn. Except for
$CRSP , I've had terrible experiences with all the small pharmaceutical and biotech companies in general. Never again. A shame for the schizophrenics, and my worst wishes to Lax and his team. Otherwise, well, at least I've been exchanging impressions and reading comments here, and this disaster has been handled with a sense of humor. Something is something, isn't it? 😂
